159 related articles for article (PubMed ID: 8554652)
21. [Determinants of unplanned discharge from in-patient drug and alcohol detoxification: a retrospective analysis of 239 admissions].
Braune NJ; Schröder J; Gruschka P; Daecke K; Pantel J
Fortschr Neurol Psychiatr; 2008 Apr; 76(4):217-24. PubMed ID: 18415929
[TBL] [Abstract][Full Text] [Related]
22. [Ambulatory detoxification of alcoholic patients--evaluation of a model project].
Soyka M; Horak M
Gesundheitswesen; 2000 Jan; 62(1):15-20. PubMed ID: 10705659
[TBL] [Abstract][Full Text] [Related]
23. Cost and outcome analysis of two alcohol detoxification services.
Parrott S; Godfrey C; Heather N; Clark J; Ryan T
Alcohol Alcohol; 2006; 41(1):84-91. PubMed ID: 16272193
[TBL] [Abstract][Full Text] [Related]
24. Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification.
Kahler CW; Read JP; Ramsey SE; Stuart GL; McCrady BS; Brown RA
J Consult Clin Psychol; 2004 Aug; 72(4):736-41. PubMed ID: 15301659
[TBL] [Abstract][Full Text] [Related]
25. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
[TBL] [Abstract][Full Text] [Related]
26. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
Gossop M; Stewart D; Marsden J
Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
[TBL] [Abstract][Full Text] [Related]
27. Neuropsychological symptoms in a cross-sectional sample of abstinent alcoholics.
O'Donnell WE; De Soto CB; De Soto JL
Psychol Rep; 1994 Dec; 75(3 Pt 2):1475-84. PubMed ID: 7886168
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of an intensive outpatient rehabilitation program in alcoholism: predictors of outcome 6 months after treatment.
Bottlender M; Soyka M
Eur Addict Res; 2005; 11(3):132-7. PubMed ID: 15990430
[TBL] [Abstract][Full Text] [Related]
29. Mirtazapine improves alcohol detoxification.
Liappas J; Paparrigopoulos T; Malitas P; Tzavellas E; Christodoulou G
J Psychopharmacol; 2004 Mar; 18(1):88-93. PubMed ID: 15107190
[TBL] [Abstract][Full Text] [Related]
30. Impact of different personality dimensions (NEO Five-Factor Inventory) on the outcome of alcohol-dependent patients 6 and 12 months after treatment.
Bottlender M; Soyka M
Psychiatry Res; 2005 Jul; 136(1):61-7. PubMed ID: 16023734
[TBL] [Abstract][Full Text] [Related]
31. Quality of life, sleep, mood and alcohol consumption: a complex interaction.
Foster JH; Peters TJ; Kind P
Addict Biol; 2002 Jan; 7(1):55-65. PubMed ID: 11900623
[TBL] [Abstract][Full Text] [Related]
32. Ethnic differences in the consequences of alcohol misuse.
Clarke M; Ahmed N; Romaniuk H; Marjot DH; Murray-Lyon IM
Alcohol Alcohol; 1990; 25(1):9-11. PubMed ID: 2334500
[TBL] [Abstract][Full Text] [Related]
33. Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes.
Humphreys K; Moos RH
Alcohol Clin Exp Res; 2007 Jan; 31(1):64-8. PubMed ID: 17207103
[TBL] [Abstract][Full Text] [Related]
34. [Community based management of alcohol dependent patients. Evaluation of a combined inpatient and ambulatory treatment concept].
Mann K; Batra A
Psychiatr Prax; 1993 May; 20(3):102-5. PubMed ID: 8378479
[TBL] [Abstract][Full Text] [Related]
35. Outcomes from primary care management of alcohol dependence in France.
Malet L; Reynaud M; Llorca PM; Chakroun N; Blanc O; Falissard B
J Subst Abuse Treat; 2009 Jun; 36(4):457-62. PubMed ID: 18835676
[TBL] [Abstract][Full Text] [Related]
36. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
[TBL] [Abstract][Full Text] [Related]
37. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
38. Six- and twelve-month abstinence rates in inpatient alcoholics treated with either faradic aversion or chemical aversion compared with matched inpatients from a treatment registry.
Smith JW; Frawley PJ; Polissar NL
J Addict Dis; 1997; 16(1):5-24. PubMed ID: 9046442
[TBL] [Abstract][Full Text] [Related]
39. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome.
Hayashida M; Alterman AI; McLellan AT; O'Brien CP; Purtill JJ; Volpicelli JR; Raphaelson AH; Hall CP
N Engl J Med; 1989 Feb; 320(6):358-65. PubMed ID: 2913493
[TBL] [Abstract][Full Text] [Related]
40. [Dependency outcome of alcohol-dependent patients after inpatient detoxification and motivation treatment].
Stetter F; Mann K
Nervenarzt; 1997 Jul; 68(7):574-81. PubMed ID: 9333719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
